"The prostate is a walnut-sized gland located behind the base of a man’s penis, in front of the rectum, and below the bladder. Cancer begins when healthy cells in the prostate change and grow out of control, forming a tumor. A tumor can be cancerous or benign. A cancerous tumor is malignant, meaning it can grow and spread to other parts of the body. A benign tumor means the tumor can grow but will not spread.

Prostate Cancer Diagnostics refers to using PSA, rectal exam, biopsy and others to diagnostic whether patients with breast cancer."

Scope of the Report:

This report focuses on the Prostate Cancer Diagnostics in North America and Europe market, especially in United States, United Kingdom, Canada, Germany, France, Italy and Spain. This report categorizes the market based on manufacturers, countries/Regions, type and application.

Market Segment by Manufacturers, this report covers

Genomic Health

Abbott

OPKO

Siemens Healthcare

DiaSorin

bioMeriux

Roche

MDx Health

Beckman Coulter

Myriad Genetics

Ambry Genetics

Market Segment by Countries, covering

United States

United Kingdom

Canada

Germany

France

Italy

Spain

Market Segment by Type, covers

Tumor Biomarker Tests

Imaging

Biopsy

Other

Market Segment by Applications, can be divided into

< 55

55-75

> 75

There are 19 Chapters to deeply display the North America and Europe Prostate Cancer Diagnostics market.

Chapter 1, to describe Prostate Cancer Diagnostics Introduction, product type and application, market overview, market analysis by countries, market opportunities, market risk, market driving force;

Chapter 2, to analyze the manufacturers of Prostate Cancer Diagnostics, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the North America and Europe market by countries, covering United States, United Kingdom, Canada, France, Germany, Italy and Spain, with sales, price, revenue and market share of Prostate Cancer Diagnostics, for each country, from 2013 to 2018;

Chapter 5 and 6, to show the market by type and application, with sales, price, revenue, market share and growth rate by type, application, from 2013 to 2018;

Chapter 7, 8, 9, 10, 11, 12 and 13 to analyze the key countries by manufacturers, Type and Application, covering 7 countries, with sales, revenue and market share by manufacturers, types and applications;

Chapter 14, Prostate Cancer Diagnostics market forecast, by countries, type and application, with sales, price, revenue and growth rate forecast, from 2018 to 2023;

Chapter 15, to analyze the manufacturing cost, key raw materials and manufacturing process, etc.

Chapter 16, to analyze the industrial chain, sourcing strategy and downstream end users (buyers);

Chapter 17, to describe sales channel, distributors, traders, dealers, etc.

Chapter 18 and 19, to describe the research findings and conclusion, appendix, methodology and data source.

Frequently Asked Questions

These dominant industry players use well planned strategies to occupied highest market share in this market. Some of the top players in [Keyword] business includes. [Company list]
As per [Keyword] market analysis, North America is forecasted to occupied major share in the [Keyword] market.
The statistical data of the dominant industry player of [Keyword] market can be acquired from the company profile segment described in the report. This segment come up with analysis of major player’s in the [Keyword] market, also their last five-year revenue, segmental, product offerings, key strategies adopted and geographical revenue produced.
The report come up with a segment of the [Keyword] market based on Type, Region, and Application, Also offer a determined view on the [Keyword] market.
The report offers a nitty-gritty estimation of the market by providing data on various viewpoints that incorporate, restraints, drivers, and opportunities threats. This data can help in making suitable decisions for stakeholders before investing.
The sample report for [Keyword] market can be received after the apply from the website.

Table Of Content

Table of Contents
1 Market Overview
    1.1 Prostate Cancer Diagnostics Introduction
    1.2 Market Analysis by Type
        1.2.1 Tumor Biomarker Tests
        1.2.2 Imaging
        1.2.3 Biopsy
        1.2.4 Other
    1.3 Market Analysis by Applications
        1.3.1 < 55
        1.3.2 55-75
        1.3.3 > 75
    1.4 Market Analysis by Countries
        1.4.1 United States Status and Prospect (2013-2023)
        1.4.2 Canada Status and Prospect (2013-2023)
        1.4.3 United Kingdom Status and Prospect (2013-2023)
        1.4.4 Germany Status and Prospect (2013-2023)
        1.4.5 France Status and Prospect (2013-2023)
        1.4.6 Italy Status and Prospect (2013-2023)
        1.4.7 Spain Status and Prospect (2013-2023)
    1.5 Market Dynamics
        1.5.1 Market Opportunities
        1.5.2 Market Risk
        1.5.3 Market Driving Force
2 Manufacturers Profiles
    2.1 Genomic Health
        2.1.1 Business Overview
        2.1.2 Prostate Cancer Diagnostics Type and Applications
            2.1.2.1 Type 1
            2.1.2.2 Type 2
        2.1.3 Genomic Health Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.2 Abbott
        2.2.1 Business Overview
        2.2.2 Prostate Cancer Diagnostics Type and Applications
            2.2.2.1 Type 1
            2.2.2.2 Type 2
        2.2.3 Abbott Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.3 OPKO
        2.3.1 Business Overview
        2.3.2 Prostate Cancer Diagnostics Type and Applications
            2.3.2.1 Type 1
            2.3.2.2 Type 2
        2.3.3 OPKO Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.4 Siemens Healthcare
        2.4.1 Business Overview
        2.4.2 Prostate Cancer Diagnostics Type and Applications
            2.4.2.1 Type 1
            2.4.2.2 Type 2
        2.4.3 Siemens Healthcare Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.5 DiaSorin
        2.5.1 Business Overview
        2.5.2 Prostate Cancer Diagnostics Type and Applications
            2.5.2.1 Type 1
            2.5.2.2 Type 2
        2.5.3 DiaSorin Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.6 bioMeriux
        2.6.1 Business Overview
        2.6.2 Prostate Cancer Diagnostics Type and Applications
            2.6.2.1 Type 1
            2.6.2.2 Type 2
        2.6.3 bioMeriux Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.7 Roche
        2.7.1 Business Overview
        2.7.2 Prostate Cancer Diagnostics Type and Applications
            2.7.2.1 Type 1
            2.7.2.2 Type 2
        2.7.3 Roche Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.8 MDx Health
        2.8.1 Business Overview
        2.8.2 Prostate Cancer Diagnostics Type and Applications
            2.8.2.1 Type 1
            2.8.2.2 Type 2
        2.8.3 MDx Health Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.9 Beckman Coulter
        2.9.1 Business Overview
        2.9.2 Prostate Cancer Diagnostics Type and Applications
            2.9.2.1 Type 1
            2.9.2.2 Type 2
        2.9.3 Beckman Coulter Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.10 Myriad Genetics
        2.10.1 Business Overview
        2.10.2 Prostate Cancer Diagnostics Type and Applications
            2.10.2.1 Type 1
            2.10.2.2 Type 2
        2.10.3 Myriad Genetics Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.11 Ambry Genetics
        2.11.1 Business Overview
        2.11.2 Prostate Cancer Diagnostics Type and Applications
            2.11.2.1 Type 1
            2.11.2.2 Type 2
        2.11.3 Ambry Genetics Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 North America and Europe Prostate Cancer Diagnostics Market Competition, by Manufacturer
    3.1 North America and Europe Prostate Cancer Diagnostics Sales and Market Share by Manufacturer (2016-2017)
    3.2 North America and Europe Prostate Cancer Diagnostics Revenue and Market Share by Manufacturer (2016-2017)
        3.2.1 North America and Europe Prostate Cancer Diagnostics Revenue by Manufacturer (2016-2017)
        3.2.2 North America and Europe Prostate Cancer Diagnostics Revenue Market Share by Manufacturer (2016-2017)
    3.3 North America and Europe Prostate Cancer Diagnostics Price by Manufacturers (2016-2017)
    3.4 Market Concentration Rate
        3.4.1 Top 3 Prostate Cancer Diagnostics Manufacturer Market Share (2016-2017)
        3.4.2 Top 5 Prostate Cancer Diagnostics Manufacturer Market Share (2016-2017)
    3.5 Market Competition Trend
4 North America and Europe Prostate Cancer Diagnostics Market Analysis by Countries/Regions
    4.1 North America and Europe Prostate Cancer Diagnostics Sales Market Share by Countries/Regions
    4.2 North America and Europe Prostate Cancer Diagnostics Sales by Countries/Regions (2013-2018)
        4.2.1 North America and Europe Prostate Cancer Diagnostics Sales by Countries/Regions (2013-2018)
        4.2.2 North America and Europe Prostate Cancer Diagnostics Sales Market Share by Countries (2013-2018)
    4.3 North America and Europe Prostate Cancer Diagnostics Revenue (Value) by Countries (2013-2018)
        4.3.1 North America and Europe Prostate Cancer Diagnostics Revenue and Growth Rate (2013-2018)
        4.3.2 North America and Europe Prostate Cancer Diagnostics Revenue Market Share by Countries (2013-2018)
5 North America and Europe Market Segmentation Prostate Cancer Diagnostics by Type
    5.1 North America and Europe Prostate Cancer Diagnostics Sales, Revenue and Market Share by Type (2013-2018)
        5.1.1 North America and Europe Prostate Cancer Diagnostics Sales and Market Share by Type (2013-2018)
        5.1.2 North America and Europe Prostate Cancer Diagnostics Revenue and Market Share by Type (2013-2018)
    5.2 Tumor Biomarker Tests Sales Growth and Price
        5.2.1 North America and Europe Tumor Biomarker Tests Sales Growth (2013-2018)
        5.2.2 North America and Europe Tumor Biomarker Tests Price (2013-2018)
    5.3 Imaging Sales Growth and Price
        5.3.1 North America and Europe Imaging Sales Growth (2013-2018)
        5.3.2 North America and Europe Imaging Price (2013-2018)
    5.4 Biopsy Sales Growth and Price
        5.4.1 North America and Europe Biopsy Sales Growth (2013-2018)
    5.5 Other Sales Growth and Price
        5.5.1 North America and Europe Other Sales Growth (2013-2018)
        5.5.2 North America and Europe Other Price (2013-2018)
6 North America and Europe Market Segmentation Prostate Cancer Diagnostics by Application
    6.1 North America and Europe Prostate Cancer Diagnostics Sales Market Share by Application (2013-2018)
    6.2 < 55 Sales Growth (2013-2018)
    6.3 55-75 Sales Growth (2013-2018)
    6.4 > 75 Sales Growth (2013-2018)
7 United States Prostate Cancer Diagnostics Sales, Revenue, by Type, Application and Manufacturers
    7.1 United States Prostate Cancer Diagnostics Revenue, Sales and Growth Rate (2013-2018)
    7.2 United States Prostate Cancer Diagnostics Sales and Market Share by Type (2013-2018)
        7.2.1 United States Prostate Cancer Diagnostics Sales by Type (2013-2018)
        7.2.2 United States Prostate Cancer Diagnostics Sales Market Share by Type (2013-2018)
    7.3 United States Prostate Cancer Diagnostics Sales and Market Share by Application (2013-2018)
        7.3.1 United States Prostate Cancer Diagnostics Sales by Application (2013-2018)
        7.3.2 United States Prostate Cancer Diagnostics Sales Market Share by Application (2013-2018)
    7.4 United States Prostate Cancer Diagnostics Sales, Revenue and Market Share by Manufacturer (2016-2017)
    7.4.1 United States Prostate Cancer Diagnostics Sales and Market Share by Manufacturer (2016-2017)
        7.4.2 United States Prostate Cancer Diagnostics Revenue and Market Share by Manufacturer (2016-2017)
    7.5 United States Prostate Cancer Diagnostics Export and Import (2013-2018)
8 United Kingdom Prostate Cancer Diagnostics Sales, Revenue, by Type, Application and Manufacturers
    8.1 United Kingdom Prostate Cancer Diagnostics Revenue, Sales and Growth Rate (2013-2018)
    8.2 United Kingdom Prostate Cancer Diagnostics Sales and Market Share by Type (2016-2017)
        8.2.1 United Kingdom Prostate Cancer Diagnostics Sales by Type (2013-2018)
        8.2.2 United Kingdom Prostate Cancer Diagnostics Sales Market Share by Type (2013-2018)
    8.3 United Kingdom Prostate Cancer Diagnostics Sales and Market Share by Application (2013-2018)
        8.3.1 United Kingdom Prostate Cancer Diagnostics Sales by Application (2013-2018)
        8.3.2 United Kingdom Prostate Cancer Diagnostics Sales Market Share by Application (2013-2018)
    8.4 United Kingdom Prostate Cancer Diagnostics Sales, Revenue and Market Share by Manufacturer (2016-2017)
        8.4.1 United Kingdom Prostate Cancer Diagnostics Sales and Market Share by Manufacturer (2016-2017)
        8.4.2 United Kingdom Prostate Cancer Diagnostics Revenue and Market Share by Manufacturer (2016-2017)
    8.5 United Kingdom Prostate Cancer Diagnostics Export and Import (2013-2018)
9 Canada Prostate Cancer Diagnostics Sales, Revenue, by Type, Application and Manufacturers
    9.1 Canada Prostate Cancer Diagnostics Revenue, Sales and Growth Rate (2013-2018)
    9.2 Canada Prostate Cancer Diagnostics Sales and Market Share by Type (2013-2018)
        9.2.1 Canada Prostate Cancer Diagnostics Sales by Type (2013-2018)
        9.2.2 Canada Prostate Cancer Diagnostics Sales Market Share by Type (2013-2018)
9.3 Canada "&Sheet1!$B$1&" Sales and Market Share by Application (2013-2018)"
        9.3.1 Canada Prostate Cancer Diagnostics Sales by Application (2013-2018)
        9.3.2 Canada Prostate Cancer Diagnostics Sales Market Share by Application (2013-2018)
    9.4 Canada Prostate Cancer Diagnostics Sales, Revenue and Market Share by Manufacturer (2016-2017)
        9.4.1 Canada Prostate Cancer Diagnostics Sales and Market Share by Manufacturer (2016-2017)
        9.4.2 Canada Prostate Cancer Diagnostics Revenue and Market Share by Manufacturer (2016-2017)
    9.5 Canada Prostate Cancer Diagnostics Export and Import (2013-2018)
10 Germany Prostate Cancer Diagnostics Sales, Revenue, by Type, Application and Manufacturers
    10.1 Germany Prostate Cancer Diagnostics Revenue, Sales and Growth Rate (2013-2018)
    10.2 Germany Prostate Cancer Diagnostics Sales and Market Share by Type (2013-2018)
        10.2.1 Germany Prostate Cancer Diagnostics Sales by Type (2013-2018)
        10.2.2 Germany Prostate Cancer Diagnostics Sales Market Share by Type (2013-2018)
    10.3 Germany Prostate Cancer Diagnostics Sales and Market Share by Application (2013-2018)
        10.3.1 Germany Prostate Cancer Diagnostics Sales by Application (2013-2018)
        10.3.2 Germany Prostate Cancer Diagnostics Sales Market Share by Application (2013-2018)
    10.4 Germany Prostate Cancer Diagnostics Sales, Revenue and Market Share by Manufacturer (2016-2017)
        10.4.1 Germany Prostate Cancer Diagnostics Sales and Market Share by Manufacturer (2016-2017)
        10.4.2 Germany Prostate Cancer Diagnostics Revenue and Market Share by Manufacturer (2016-2017)
    10.5 Germany Prostate Cancer Diagnostics Export and Import (2013-2018)
11 France Prostate Cancer Diagnostics Sales, Revenue, by Type, Application and Manufacturers
    11.1 France Prostate Cancer Diagnostics Revenue, Sales and Growth Rate (2013-2018)
    11.2 France Prostate Cancer Diagnostics Sales and Market Share by Type (2013-2018)
        11.2.1 France Prostate Cancer Diagnostics Sales by Type (2013-2018)
        11.2.2 France Prostate Cancer Diagnostics Sales Market Share by Type (2013-2018)
11.3 France "&Sheet1!$B$1&" Sales by Application (2013-2018)"
        11.3.1 France Prostate Cancer Diagnostics Sales by Application (2013-2018)
        11.3.2 France Prostate Cancer Diagnostics Sales Market Share by Application (2013-2018)
    11.4 France Prostate Cancer Diagnostics Sales, Revenue and Market Share by Manufacturer (2016-2017)
        11.4.1 France Prostate Cancer Diagnostics Sales and Market Share by Manufacturer (2016-2017)
        11.4.2 France Prostate Cancer Diagnostics Revenue and Market Share by Manufacturer
    11.5 France Prostate Cancer Diagnostics Export and Import (2013-2018)
12 Italy Prostate Cancer Diagnostics Sales, Revenue, by Type, Application and Manufacturers
    12.1 Italy Prostate Cancer Diagnostics Revenue, Sales and Growth Rate (2013-2018)
    12.2 Italy Prostate Cancer Diagnostics Sales and Market Share by Type (2013-2018)
        12.2.1 Italy Prostate Cancer Diagnostics Sales by Type (2013-2018)
        12.2.2 Italy Prostate Cancer Diagnostics Sales Market Share by Type (2013-2018)
    12.3 Italy Prostate Cancer Diagnostics Sales and Market Share by Application (2013-2018)
        12.3.1 Italy Prostate Cancer Diagnostics Sales by Application (2013-2018)
        12.3.2 Italy Prostate Cancer Diagnostics Sales Market Share by Application (2013-2018)
    12.4 Italy Prostate Cancer Diagnostics Sales, Revenue and Market Share by Manufacturer (2016-2017)
        12.4.1 Italy Prostate Cancer Diagnostics Sales and Market Share by Manufacturer (2016-2017)
        12.4.2 Italy Prostate Cancer Diagnostics Revenue and Market Share by Manufacturer (2016-2017)
    12.5 Italy Prostate Cancer Diagnostics Export and Import (2013-2018)
13 Spain Prostate Cancer Diagnostics Sales, Revenue, by Type, Application and Manufacturers
    13.1 Spain Prostate Cancer Diagnostics Revenue, Sales and Growth Rate (2013-2018)
    13.2 Spain Prostate Cancer Diagnostics Sales and Market Share by Type (2013-2018)
        13.2.1 Spain Prostate Cancer Diagnostics Sales by Type (2013-2018)
        13.2.2 Spain Prostate Cancer Diagnostics Sales Market Share by Type (2013-2018)
    13.3 Spain Prostate Cancer Diagnostics Sales by Application (2013-2018)
        13.3.1 Spain Prostate Cancer Diagnostics Sales by Application (2013-2018)
        13.3.2 Spain Prostate Cancer Diagnostics Sales Market Share by Application (2013-2018)
    13.4 Spain Prostate Cancer Diagnostics Sales, Revenue and Market Share by Manufacturer (2016-2017)
        13.4.1 Spain Prostate Cancer Diagnostics Sales and Market Share by Manufacturer (2016-2017)
        13.4.2 Spain Prostate Cancer Diagnostics Revenue and Market Share by Manufacturer (2016-2017)
    13.5 Spain Prostate Cancer Diagnostics Export and Import (2013-2018)
14 Prostate Cancer Diagnostics Market Forecast (2018-2023)
    14.1 North America and Europe Prostate Cancer Diagnostics Sales, Revenue and Growth Rate (2018-2023)
    14.2 Prostate Cancer Diagnostics Market Forecast by Countries/Regions (2018-2023)
        14.2.1 United States Prostate Cancer Diagnostics Sales and Growth Rate Forecast (2018-2023)
        14.2.2 United Kingdom Prostate Cancer Diagnostics Sales and Growth Rate Forecast (2018-2023)
        14.2.3 Canada Prostate Cancer Diagnostics Sales and Growth Rate Forecast (2018-2023)
        14.2.4 Germany Prostate Cancer Diagnostics Sales and Growth Rate Forecast (2018-2023)
        14.2.5 France Prostate Cancer Diagnostics Sales and Growth Rate Forecast (2018-2023)
        14.2.6 Italy Prostate Cancer Diagnostics Sales and Growth Rate Forecast (2018-2023)
        14.2.7 Spain Prostate Cancer Diagnostics Sales and Growth Rate Forecast (2018-2023)
14.3 Prostate Cancer Diagnostics Market Forecast by Type (2018-2023)
        14.3.1 North America and Europe Prostate Cancer Diagnostics Sales Forecast by Type (2018-2023)
        14.3.2 North America and Europe Prostate Cancer Diagnostics Market Share Forecast by Type (2018-2023)
14.4 Prostate Cancer Diagnostics Market Forecast by Application (2018-2023)
        14.4.1 North America and Europe Prostate Cancer Diagnostics Sales Forecast by Application (2018-2023)
        14.4.2 North America and Europe Prostate Cancer Diagnostics Market Share Forecast by Application (2018-2023)
15 Prostate Cancer Diagnostics Manufacturing Cost Analysis
    15.1 Prostate Cancer Diagnostics Key Raw Materials Analysis
        15.1.1 Key Raw Materials
        15.1.2 Price Trend of Key Raw Materials
        15.1.3 Key Suppliers of Raw Materials
        15.1.4 Market Concentration Rate of Raw Materials
    15.2 Proportion of Manufacturing Cost Structure
        15.2.1 Raw Materials
        15.2.2 Labor Cost
        15.2.3 Manufacturing Expenses
    15.3 Manufacturing Process Analysis of Prostate Cancer Diagnostics
16 Industrial Chain, Sourcing Strategy and Downstream Buyers
    16.1 Prostate Cancer Diagnostics Industrial Chain Analysis
    16.2 Upstream Raw Materials Sourcing
    16.3 Raw Materials Sources of Prostate Cancer Diagnostics Major Manufacturers in 2017
    16.4 Downstream Buyers
17 Sales Channel, Distributors, Traders and Dealers
    17.1 Sales Channel
        17.1.1 Direct Marketing
        17.1.2 Indirect Marketing
        17.1.3 Marketing Channel Future Trend
    17.2 Distributors, Traders and Dealers
18 Research Findings and Conclusion
19 Appendix
    19.1 Methodology
    19.2 Data Source

Inquiry For Buying

North America and Europe Prostate Cancer Diagnostics

Please fill out the form. We will contact you within 24 hours:
All fields required...

Request Sample

North America and Europe Prostate Cancer Diagnostics

Please fill out the form. We will contact you within 24 hours:
All fields required...

×

Avail Free PDF Sample Report

This website is secure and your personal details are safe. Privacy Policy

Thank you for contacting us.

Thank you for your interest in our research report.

We will be sending you the sample copy of the report shortly. Meanwhile, if you have any specific research requirement then please let us know. We will be glad to assist you in case you have any additional questions, so feel free to get in touch

Thank you

Warm regards,
Sales | Manager - International Business and partner Relations
Direct line: +1 347 535 0815
Market Research Store
E-mail: sales@MarketResearchStore.com | Web: www.MarketResearchStore.com